Search - tctmd.com

Displaying 1 - 20 of 85

Sort: Relevancy | Date

News Conference News TCT 2022

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

Michael O'Riordan

September 19, 2022

News Conference News TCT 2022

RADIANCE II Confirms Ultrasound-Based Renal Denervation Lowers BP

Todd Neale

September 18, 2022

News Conference News TCT 2021

Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints

Todd Neale

November 04, 2021

News Conference News TCT 2020

Treating Accessory Arteries May Be Important in Renal Denervation

Todd Neale

October 18, 2020

News Conference News TCT 2018

RADIOSOUND-HTN Suggests Ultrasound May Be Best for Renal Denervation

Todd Neale

September 26, 2018

News Conference News TCT 2018

Prematurely Halted Pilot Study Snaps Recent Winning Streak for Renal Denervation

Todd Neale

September 25, 2018

News Conference News TCT 2018

Untreated Accessory Arteries Dampen Renal Denervation Response: RADIANCE-HTN SOLO

Todd Neale

September 21, 2018

News Conference News TCT 2015

SYMPLICITY HTN-3 Results Continue to Spur Discussion

October 11, 2015

Presentation TCT 2014

Thoughtful Insights

Presenter: Krishna J. Rocha-Singh

September 17, 2014

Presentation TCT 2014

Case Presentation

Presenter: Justin E. Davies

September 17, 2014

Presentation TCT 2014

Noninvasive Renal Denervation Using Externally Delivered Focused Ultrasound: Early Experience Using Doppler-Based Imaging Tracking and Targeting for Treatment

Presenter: Michael Joner, Horst Sievert, Steven L. Almany, John A. Ormiston

September 16, 2014

Presentation TCT 2014

What Is the Clinical Trial Pathway Moving Forward for Renal Denervation?

Presenter: Ajay J. Kirtane, Bram D. Zuckerman, Paul A. Sobotka

September 16, 2014

Presentation TCT 2014

Global Perspectives in the Post-HTN-3 Era: A Kinder and Gentler Interpretation of Renal Denervation Therapy

Presenter: Ajay J. Kirtane, Bram D. Zuckerman, Paul A. Sobotka, Felix Mahfoud

September 16, 2014

Presentation TCT 2014

New Insights from SYMPLICITY HTN-3 What I Learned and What I Would Have Done Differently

Presenter: Ajay J. Kirtane, Bram D. Zuckerman, Paul A. Sobotka, Deepak L. Bhatt

September 16, 2014

$Symplicity Flex: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Mild Refractory Hypertension$

Presentation TCT 2014

Symplicity Flex: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Mild Refractory Hypertension

Presenter: Ajay J. Kirtane, Deepak L. Bhatt, Steffen Desch

September 16, 2014

Presentation TCT 2014

CON Problematic and Challenged

Presenter: Deepak L. Bhatt

September 16, 2014

Presentation TCT 2014

PRO Continued Optimism

Presenter: Felix Mahfoud

September 16, 2014

Presentation TCT 2014

Renal Artery Denervation With A New Simultaneous Multielectrode Catheter For Treatment Of Resistant Hypertension: 12-Month Update From The SYMPLICITY Spyral First-In-Man Study

Presenter: Robert Whitbourn

September 16, 2014

Presentation TCT 2014

First Clinical Experience with Neurotropic Agents for Treatment of Sympathetic Hypertension

Presenter: Horst Sievert

September 16, 2014

Presentation TCT 2014

CATHETER-BASED RENAL SYMPATHETIC DENERVATION FOR RESISTANT HYPERTENSION: A META-ANALYSIS OF RANDOMIZED TRIALS

Presenter: Daniel Garcia

September 16, 2014

Advertisement

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

RADIANCE II Confirms Ultrasound-Based Renal Denervation Lowers BP

Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints

Treating Accessory Arteries May Be Important in Renal Denervation

RADIOSOUND-HTN Suggests Ultrasound May Be Best for Renal Denervation

Prematurely Halted Pilot Study Snaps Recent Winning Streak for Renal Denervation

Untreated Accessory Arteries Dampen Renal Denervation Response: RADIANCE-HTN SOLO

SYMPLICITY HTN-3 Results Continue to Spur Discussion

Thoughtful Insights

Case Presentation

Noninvasive Renal Denervation Using Externally Delivered Focused Ultrasound: Early Experience Using Doppler-Based Imaging Tracking and Targeting for Treatment

What Is the Clinical Trial Pathway Moving Forward for Renal Denervation?

Global Perspectives in the Post-HTN-3 Era: A Kinder and Gentler Interpretation of Renal Denervation Therapy

New Insights from SYMPLICITY HTN-3 What I Learned and What I Would Have Done Differently

Symplicity Flex: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Mild Refractory Hypertension

CON Problematic and Challenged

PRO Continued Optimism

Renal Artery Denervation With A New Simultaneous Multielectrode Catheter For Treatment Of Resistant Hypertension: 12-Month Update From The SYMPLICITY Spyral First-In-Man Study

First Clinical Experience with Neurotropic Agents for Treatment of Sympathetic Hypertension

CATHETER-BASED RENAL SYMPATHETIC DENERVATION FOR RESISTANT HYPERTENSION: A META-ANALYSIS OF RANDOMIZED TRIALS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content